Skip to content

Clinical trials

Phase 2/3 Carcinoma, Non-Small-Cell Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2/3 Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20152
20171
20181
20203
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting3
Completed3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
AbbVie1
Alpha Biopharma (Jiangsu) Co., Ltd.1
BioNTech SE1
Bristol-Myers Squibb1
Clovis Oncology, Inc.1
Dong-A University Hospital1
Eikon Therapeutics1
GlaxoSmithKline1
Il Yeong Park, Ph.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms4
Neoplasms3
Brain Neoplasms1
Colorectal Neoplasms1
Neoplasm Metastasis1
Pancreatic Neoplasms1
Recurrence1
Respiratory Tract Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.